These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 23806493)

  • 21. [Chemoprevention of prostate cancer].
    Djavan B; Thompson I; Michel MS; Waldert M; Seitz C
    Urologe A; 2004 May; 43(5):557-61. PubMed ID: 15042290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of prostate cancer: agents and study designs.
    Thompson IM
    J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial.
    Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
    J Urol; 2001 Oct; 166(4):1311-5. PubMed ID: 11547064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoprevention of prostate cancer.
    Kucuk O
    Cancer Metastasis Rev; 2002; 21(2):111-24. PubMed ID: 12465750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
    Klein EA
    Recent Results Cancer Res; 2003; 163():212-25; discussion 264-6. PubMed ID: 12903856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III prostate cancer chemoprevention trials.
    Parnes HL; Brawley OW; Minasian LM; Ford LG
    Recent Results Cancer Res; 2014; 202():73-7. PubMed ID: 24531780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of prostate cancer.
    Vemana G; Hamilton RJ; Andriole GL; Freedland SJ
    Annu Rev Med; 2014; 65():111-23. PubMed ID: 24188663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention of prostate cancer.
    Stephenson AJ; Abouassaly R; Klein EA
    Urol Clin North Am; 2010 Feb; 37(1):11-21, Table of Contents. PubMed ID: 20152515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in prostate cancer chemoprevention: a translational perspective.
    Nambiar D; Singh RP
    Nutr Cancer; 2013; 65 Suppl 1():12-25. PubMed ID: 23682779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer chemoprevention: current status and future prospects.
    Gupta S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Dunn BK; Richmond ES; Minasian LM; Ryan AM; Ford LG
    Nutr Cancer; 2010; 62(7):896-918. PubMed ID: 20924966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention: an important treatment option for prostate cancer.
    Calvert RC; Thompson CS; Mikhailidis DP; Morgan RJ
    J R Soc Promot Health; 2000 Sep; 120(3):146-7. PubMed ID: 11077795
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge.
    Andriole G; Bostwick D; Civantos F; Epstein J; Lucia MS; McConnell J; Roehrborn CG
    J Urol; 2005 Dec; 174(6):2098-104. PubMed ID: 16280736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of prostate cancer.
    Rittmaster RS
    Acta Oncol; 2011 Jun; 50 Suppl 1():127-36. PubMed ID: 21604953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.
    Ledesma MC; Jung-Hynes B; Schmit TL; Kumar R; Mukhtar H; Ahmad N
    Mol Med; 2011; 17(1-2):134-43. PubMed ID: 20882260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on chemoprevention strategies in prostate cancer for 2006.
    Neill MG; Fleshner NE
    Curr Opin Urol; 2006 May; 16(3):132-7. PubMed ID: 16679848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Finasteride as a chemopreventive agent in prostate cancer: impact of the PCPT on urologic practice.
    Goetzl MA; Holzbeierlein JM
    Nat Clin Pract Urol; 2006 Aug; 3(8):422-9. PubMed ID: 16902518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of aspirin, vitamin E raises questions for future chemoprevention studies.
    Hayasaka E
    J Natl Cancer Inst; 2005 Sep; 97(17):1242-3. PubMed ID: 16145040
    [No Abstract]   [Full Text] [Related]  

  • 39. Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
    Lippman SM; Lee JJ
    Cancer Res; 2006 Mar; 66(6):2893-903. PubMed ID: 16540634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate cancer: a serious disease suitable for prevention.
    Fitzpatrick JM; Schulman C; Zlotta AR; Schröder FH
    BJU Int; 2009 Apr; 103(7):864-70. PubMed ID: 19302133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.